V029-4667 Screening compound: N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide

V029-4667 Screening compound: N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide
V029-4667 Screening compound: N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-4667
N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-4667

Molecular Formula

C26H26F6N4O3 (C26 H26 F6 N4 O3)

Compound Name

N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide

IUPAC name

N-[3-(morpholin-4-yl)propyl]-4-(trifluoromethyl)-N-(2-{3-[3-(trifluoromethyl)phenyl]-124-oxadiazol-5-yl}ethyl)benzamide

SMILES

O=C(c1ccc(C(F)(F)F)cc1)N(CCCN1CCOCC1)CCc1nc(-c2cccc(C(F)(F)F)c2)no1

InChI

InChI=1S/C26H26F6N4O3/c27-25(28,29)20-7-5-18(6-8-20)24(37)36(11-2-10-35-13-15-38-16-14-35)12-9-22-33-23(34-39-22)19-3-1-4-21(17-19)26(30,31)32/h1,3-8,17H,2,9-16H2

InChI Key

WQQVDXXIHCSZFG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19791268

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

556.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.930

Distribution Coefficient, logD

4.707

Water Solubility, LogSw

-5.03

Polar Surface Area

59.369

Acid Dissociation Constant (pKa)

27.84

Base Dissociation Constant (pKb)

7.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

V029-4667 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V029-4667 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-4667?
Check Price and Availability of V029-4667, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-4667 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-4667
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-4667
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-4667 available by request